Loading organizations...
§ Private Profile · 60 Sloane Avenue, London, SW3 3DD, United Kingdom
Digital healthcare company providing AI-powered symptom checking and virtual consultations with doctors for patients and health systems.
Babylon is a digital healthcare company originally based in London and later Austin, Texas, that provides AI-powered symptom checking, virtual medical consultations, and primary care services. At its peak, the platform covered over 24 million patients across 15 countries and generated $128.8 million in revenue during the first half of 2021. The company secured major contracts with the UK's National Health Service and received financial backing from prominent investors including the Saudi Public Investment Fund, Kinnevik AB, and Palantir. After reaching a $4.2 billion valuation through a 2021 SPAC merger on the New York Stock Exchange, the business faced mounting financial losses and filed for bankruptcy in 2023. Following the collapse, the US-based digital health firm eMed acquired the remaining United Kingdom operations of the enterprise, which was originally founded in 2013 by Ali Parsa.
Babylon has raised $631.0M across 4 funding rounds.
Key people at Babylon.
Babylon was founded in 2013 by Ali Parsa (Founder and CEO).
Babylon has raised $631.0M in total across 4 funding rounds.
Babylon has raised $631.0M across 4 funding rounds. Most recently, it raised $550.0M Series C in August 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 9, 2024 | Build on Bitcoin | $1.6M Other Equity | Marguerite DE Tavernost | Aave Foundation, BlackRock, Centrifuge, Curve, Injective, Magic Eden, Mechanism, Ordinals, Rarible, MacLane Wilkison, Vessel Capital |
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 1, 2019 | $550M Series C | — | Accel, General Catalyst, Northzone, Georgi Ganev, Munich RE, Public Investment Fund | Announced |
| Apr 1, 2017 | $60M Series B | — | Accel, General Catalyst, Northzone, Kinnevik, NNS Holdings | Announced |
| Jan 1, 2016 | $14M Series A | Lorenzo Grabau | Accel, General Catalyst, Northzone, Adam Balon, Demis Hassabis, JON Wright, Richard Reed, Hoxton Ventures | Announced |
| Aug 1, 2015 | $7M Seed | — | Hoxton Ventures | Announced |
Key people at Babylon.
# High-Level Overview
Babylon is a digital-first healthcare company that leverages artificial intelligence and virtual clinical services to make healthcare more accessible and affordable globally.[1][2] Founded in 2013, the company operates a subscription-based model combining AI-powered diagnostic tools, virtual consultations with healthcare professionals, and continuous health monitoring through its mobile and web applications.[2][3] Babylon serves patients across 17 countries and has expanded significantly in the United States through its Babylon 360 service, which functions as a digital primary care platform integrated with networks of physicians and specialists.[3][4]
The company's core mission centers on shifting healthcare from reactive sick care to preventative care, enabling users to access quality medical services 24/7 from their devices.[1][4] Rather than building a traditional healthcare infrastructure, Babylon operates as a technology-enabled care provider, partnering with health plans, governments, and medical networks to deliver services at scale.[4] With approximately 470 employees and operations spanning multiple continents, Babylon positions itself as a leader in value-based care—a model where providers are incentivized to improve patient outcomes while reducing costs.[1][4]
Babylon was founded in 2013 by Dr. Ali Parsa, a healthcare entrepreneur with significant industry experience as the former CEO of Circle Health hospital operator and an investment banker.[3] Parsa's vision emerged from recognizing a fundamental gap in healthcare accessibility—the belief that everyone deserves affordable, quality medical services regardless of location or financial status.[2] This founding insight directly shaped the company's technology-first approach to democratizing healthcare.
The company achieved early credibility through regulatory validation: in 2014, Babylon Health Services Ltd. became the first digital health service of its kind to be registered with the UK's Care Quality Commission, the healthcare regulator in England.[3] A pivotal expansion moment came through its partnership with the UK's National Health Service (NHS) to provide digital healthcare services, establishing Babylon's credibility as a legitimate healthcare provider rather than merely a software vendor.[2] By 2019, the company had scaled to cover over 20 million people and was conducting more than 5,000 consultations daily.[3]
Babylon operates at the intersection of three powerful healthcare trends: digital transformation of clinical delivery, AI adoption in diagnostics and triage, and value-based care economics. The timing is critical—healthcare systems globally face capacity constraints and cost pressures, while consumer expectations for digital-first services have normalized through fintech and other sectors. Babylon's model directly addresses these forces by reducing friction in healthcare access while improving financial outcomes for payers.
The company influences the broader ecosystem by demonstrating that technology companies can operate as legitimate healthcare providers rather than remaining confined to software roles. This challenges traditional healthcare incumbents and validates the venture-backed digital health model at scale. Babylon's expansion across 17 countries and integration with government health systems (NHS) and major U.S. health plans signals that digital-first care is becoming infrastructure rather than novelty.
Babylon's trajectory suggests continued expansion in value-based care markets where digital integration creates genuine cost and outcome advantages. The company's focus on Medicare Advantage and Medicaid populations in the U.S. positions it to benefit from the ongoing shift toward managed care models. Key challenges ahead include regulatory complexity across markets, clinical quality maintenance at scale, and competition from both digital health startups and traditional healthcare systems building their own digital capabilities.
The company's influence will likely deepen as AI capabilities mature—moving beyond symptom checking toward predictive health analytics and personalized preventative interventions. If Babylon successfully demonstrates that digital-first, AI-enabled care can deliver superior outcomes at lower cost, it could reshape how healthcare systems globally organize clinical delivery, making the company not just a service provider but a model for healthcare's digital future.
Babylon was founded in 2013 by Ali Parsa (Founder and CEO).
Babylon has raised $631.0M in total across 4 funding rounds.
Babylon's investors include Accel, General Catalyst, Northzone, Georgi Ganev, Munich Re, Public Investment Fund, Kinnevik, NNS Holdings, Lorenzo Grabau, Adam Balon, Demis Hassabis, Jon Wright.